Hologic, Inc today expanded its
Myosure portfolio by adding the MyoSure MANUAL device which enables physicians to more easily resect and remove
intrauterine polyps and fibroids in office settings when used along with the
MyoSure hysteroscope.
The device comes with
an ergonomically designed blade that can be rotated through 360 degrees,
enabling wide range of smooth motion. The system does not require cauterization
and have a transparent tissue trap that allows the physician to see the
specimen and can holds up to 4gms of tissue.
The
tissue trap can be detached, and the specimen can be sent for direct
histopathological examination.
In addition, the
system also comes with a built-in vacuum, eliminating the need of external
suction and works with a one-liter saline bag.
The complete MyoSure system is a
minimally invasive hysteroscopic treatment for women with Abnormal Uterine
Bleeding (AUB) due to polyps or fibroids and requires no cauterization, which
preserves uterine form and function.
Edward Evantash, M.D., Medical
Director and Vice President of Medical Affairs, Hologic said in a press
release, “We recognize the increased demand for in-office procedures, and seek
to develop innovative solutions to provide flexibility and convenience for both
physicians and patients. The MyoSure MANUAL device was designed for in-office
tissue removal procedures, requiring minimal setup and no vacuum or fluid
management system, while offering direct visualization when used with the
MyoSure hysteroscope."
“The MyoSure MANUAL device is an exciting
addition to Hologic's growing portfolio of gynecologic solutions, developed
with the patient and physician in mind. This addition to the MyoSure product
suite signals our ongoing commitment to providing effective surgical solutions
that can be performed in office to address our customers' needs and improve the
overall patient experience," added Sean Daugherty, President of GYN
Surgical Solutions at Hologic.
Contraindications for the use of MyoSure
MANUAL Tissue Removal Device includes pregnancy
or suspected pregnancy, has clinical evidence of an active pelvic infection or
history of a recent pelvic infection, or has cervical malignancies or
previously diagnosed uterine cancer.
Other devices in Myosure Portfolio
include MyoSure®, MyoSure® REACH, MyoSure® XL,
and MyoSure®LITE devices.
Complete MyoSure MANUAL device
Instructions for use
No comments:
Post a Comment